Bispecific immune-angiogenic blockade in extensive-stage small-cell lung cancer—positioning ivonescimab

Chinese Clinical Oncology 2026 Open access

Read full text
Authors: Èlia Sais, Joaquim Bosch‐Barrera
DOI: 10.21037/cco-2025-aw-127
Cited by: 0

Fields of Study & Subjects

Lung Cancer Research Studies Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Chinese Clinical Oncology
Volume
15
Issue
1
Pages
20–20
Publication date
1 February 2026
Language
EN